期刊文献+

多参数TOX免疫表型法的建立及在母细胞性浆细胞样树突状细胞肿瘤中的应用 被引量:1

Establishment of multi-parameter immunophenotypic assay for TOX expression and its application for the patient with BPDCN
下载PDF
导出
摘要 目的:建立多参数流式检测胸腺细胞选择相关高迁移率族蛋白(TOX)在PD-1、Tim-3和CD244耗竭性T细胞中的免疫表型法,以及其在1例罕见CD4-CD56^(+)表型的血液恶性肿瘤母细胞性浆细胞样树突状细胞肿瘤(BPDCN)患者中的应用分析。方法:收集1例BPDCN患者骨髓(BM)和外周血(PB),2例非肿瘤手术患者和1例健康者BM以及11例健康者(HI)PB分别作为BM和PB对照组,利用多色流式单抗CD45、CD3、CD4、CD8、CD25、FoxP3、TOX、PD-1、Tim-3、CD244及相应同型对照进行流式细胞检测。结果:流式检测结果提示,BPDCN患者BM和PB中TOX^(+)CD3^(+)、TOX^(+)CD4^(+)和TOX^(+)CD8^(+)T细胞比例均比对照组升高;BPDCN患者BM和PB中TOX^(+)PD-1^(+)CD8^(+)、TOX^(+)Tim-3^(+)CD8^(+)和TOX^(+)CD244^(+)CD8^(+)耗竭性T细胞中的分布比例也显著高于对照组。此外,在BPDCN患者BM和PB的CD4^(+)CD25^(+)FoxP3^(+)Treg细胞中TOX^(+)细胞分布比例高于对照组;同时TOX^(+)细胞在PD-1^(+)CD4^(+)CD25^(+)FoxP3^(+)Treg、Tim-3^(+)CD4^(+)CD25^(+)FoxP3^(+)Treg和CD244^(+)CD4^(+)CD25^(+)FoxP3^(+)Treg耗竭性T细胞中的分布比例也明显高于对照组。结论:成功建立多参数流式细胞术检测PD-1、Tim-3和CD244耗竭性T细胞亚群中TOX免疫表型法,TOX可能是BPDCN患者T细胞免疫调节的重要转录因子。 Objective:To establish a multi-parameter flow cytometry method for detecting the immunophenotypes of thymocyte selection-associated high mobility group box protein(TOX)expression and co-expression with programmed death 1(PD-1),T cell immunoglobulin domain and mucin domain-containing molecule 3(Tim-3)and CD244 in T cell subsets,and analyze the immune suppression characteristic in a patient with blastic plasmacytoid dendritic cell neoplasm(BPDCN).Methods:The peripheral blood(PB)and bone marrow(BM)of one patient with BPDCN were collected,while BM of non-tumor surgery(2 cases and 1 healthy donor),PB of 11 healthy individuals severed as control.The monoclonal antibodies CD45,CD3,CD4,CD8,CD25,FoxP3,TOX,PD-1,Tim-3,CD244 and corresponding isotype controls were employed in polychromatic flow cytometry detection.Results:The proportion of TOX^(+)CD3^(+),TOX^(+)CD4^(+)and TOX^(+)CD8^(+)T cells in BM and PB of the patient with BPDCN was higher than that of healthy control.Moreover,the percentage of TOX^(+)PD-1^(+)CD8^(+),TOX^(+)Tim-3^(+)CD8^(+)and TOX^(+)CD244^(+)CD8^(+)cells in BM or PB from the BPDCN patient was also higher than that from control.In addition,an increased percentage of TOX^(+)cells among CD4^(+)CD25^(+)FoxP3^(+)Treg cells in BM or PB of the BPDCN patients was observed in comparison with healthy individuals.And the number of TOX^(+)cells among the PD-1^(+)CD4^(+)CD25^(+)FoxP3^(+)Treg,Tim-3^(+)CD4^(+)CD25^(+)FoxP3^(+)Treg and CD244^(+)CD4^(+)CD25^(+)FoxP3^(+)Treg was also higher than that of healthy individuals.Conclusion:The detection of TOX expression and co-expression with PD-1,Tim-3 and CD244 in T cell subsets are successfully established using multi-parameter flow cytometry,and TOX may be an important transcription factor in T cell immune regulation of BPDCN patient.
作者 赵玉洁 黄舒欣 翁泽平 卢育洪 李扬秋 陈少华 ZHAO Yujie;HUANG Shuxin;WENG Zeping;LU Yuhong;LI Yangqiu;CHEN Shaohua(Institute of Hematology,School of Medicine,the First Affiliated Hospital,Jinan University,Guangzhou 510632,Guangdong,China;Department of Pathology,the First Affiliated Hospital,the First Affiliated Hospital,Jinan University,Guangzhou 510632,Guangdong,China;Department of Hematology,the First Affiliated Hospital,Jinan University,Guangzhou 510632,Guangdong,China)
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2022年第2期149-158,共10页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 国家自然科学基金项目(81570143,82070152,91642111)。
关键词 胸腺细胞选择相关高迁移率族蛋白(TOX) 流式细胞术 母细胞性浆细胞样树突状细胞肿瘤(BPDCN) PD-1 TIM-3 CD244 TOX(thymocyte selection-associated high mobility group box protein) flow cytometry blastic plasmacytoid dendritic cell neoplasm(BPDCN) PD-1 Tim-3 CD244
  • 相关文献

参考文献1

二级参考文献39

  • 1REAGAN J L, FAST L D, SAFRAN H, et al. Cellularimmunotherapy for refractory hematological malignancies[J]. J Transl Med, 2013,11(1) :150.
  • 2LICHTENEGGER F S,SCHNORFEIL F M,HIDDE-MANN W, et al. Current strategies in immunotherapy foracute myeloid leukemia [ J ]. Immunotherapy, 2013, 5(1):63 -78.
  • 3CHEN S, YANG L,CHEN S, et al. TCR zeta chain ex-pression in T cells from patients with CML[ J]. Hematol-ogy, 2009, 14(2) : 95 - 10.
  • 4闫小娟,查显丰,沈琦,等.慢性粒细胞白血病患者FceRIy链基因表达上调[J].暨南大学学报:医学版,2011,32(4):379 -382.
  • 5LI Y, GENG S, DU X,et al. Restricted TRBV reper-toire in CD4 + and CD8 + T-cell subsets from patientswith CML[ J] . Hematology, 2011, 16( 1 ) :43 -49.
  • 6LI Y, GENG S,YIN Q,et al. Decreased level of recentthymic emigrants in CD4 + and CD8 + T cells from pa-tients with CML[ J]. J Transl Med, 2010,8:47.
  • 7TORELLI GF,PAOLINI R,TATARELLI C, et al. De-fective expression of the T-cell receptor-CD3 zeta chain inT-cell acute lymphoblastic leukaemia [ J ]. Br J Haema-tol, 2003,120(2) :201 -208.
  • 82HA X,CHEN S,YANG L,et al. Up-regulated TCR^enhances interleukin-2 production in T-cells from patientswith CML[J]. DNA Cell Biol, 2012,31(11) : 1628 -1635.
  • 9CHEN J, SCHMITT A,CHEN B, et al. Imatinib impairsCD8 + T lymphocytes specifically directed against theleukemia-associated antigen RHAMM/CD168 in vitro[J]. Cancer Immunol Immunother,2007 , 56(6) :849 -861.
  • 10ZHA X,CHEN S, YANG L, et al. Characterization ofthe CDR3 structure of Vp21 T cell clone in patients withP2jqBck-ablp0gjtjve CML and B-ALL[ J]. Hum Immunol,2011,72(10) :798 -804.

共引文献3

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部